Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adnab, Aerami, Algernon, Alterity, Antibe, Apollomics, Applied Biomath, Arch, Area, Azurrx, Basilea, Bostongene, Camargo, Cellular Biomedicine, Chance, Charles River, Compass Pathways, Edison, Eikonizo, Eloxx, Evotec, Freeline, Hengrui, Herantis, Homology, Hoth, Jemincare, Jubilant, Lannett, Lassen, Merck & Co., Nanoform, Nuance, Otsuka, Pfizer, PPD, Respirerx, Revitope, Sigilon, Sorrento, Stemedix, Synaptogenix, Taysha, Tmunity, Tryp, Yingli.